A neurosurgeon at the Methodist Neurological Institute (NI) found a new way to label nanotubes using quantum dots, a discovery that could give researchers a new view into cancer cells, proteins, and DNA molecules.
1) Investigational neuroprotectant for stroke showing positive signs; 2) Investigational NeuroFlo device for ischemic stroke; 3) Interventional stroke treatment uses first FDA-approved brain stent; 4) Implanted pump targets spasticity in stroke patients
A unique music therapy study, funded by the GRAMMY Foundation, is underway at the Methodist Neurological Institute (NI) in Houston. Dr. Ron Tintner, a neurologist at the NI and a participating physician in Methodist's Center for Performing Arts Medicine program, is studying music as a way to help treat Parkinson's disease patients.
A five-year follow-up study finds that a combination of radiation and suicide gene therapy is eliminating the spread of prostate cancer and providing a long term vaccine against the disease.
A unique clinical study found only at the Methodist Neurological Institute (NI) in Houston is looking at the benefits of Lipitor on the immune system in patients with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS).
Research conducted at the Methodist DeBakey Heart Center in Houston shows a 70 percent reduction in LDL-c, or bad cholesterol, using a combination therapy of two statin drugs. This is the largest reduction in bad cholesterol ever seen in a statin clinical trial.
Research conducted by retina surgeons at The Methodist Hospital has contributed to FDA approval of a new wonder drug for patients affected by one of the leading causes of blindness in people over 60.
A clinical trial under way at The Methodist Hospital in Houston is studying the use of stent grafts to treat thoracic aortic aneurysms in high-risk, emergency situations, such as a ruptured aortic aneurysms or tears in the aorta caused by trauma.
A medical/health tip sheet from The Methodist Hospital in Houston, covering topics ranging from a new sinus procedure to software that allows physicians to understand blood flow in the brain.
Patients who undergo significant weight loss often need behavioral and social therapy to address issues around intimacy. This is an aspect of obesity that is rarely discussed.
Computer-assisted devices can now offer patients an alternative to traditional physical rehabilitation and medical treatment for stroke, brain injuries and spinal cord injuries.
Research conducted at the Methodist DeBakey Heart Center in Houston shows that a combination statin therapy already proven to lower bad cholesterol by a dramatic 70 percent, now has the added benefit of reducing life-threatening inflammation that can lead to heart disease.
Research conducted by retina surgeons at The Methodist Hospital shows unprecedented improvements in vision in more than one-third of patients treated with Lucentisâ„¢ for wet age-related macular degeneration (AMD), according to findings published in the New England Journal of Medicine.
A novel toxin resembling a snake venom poison contributes to severe group A Streptococcus "flesh-eating" infections. This discovery provides promise for the development of new therapies to treat some forms of these life-threatening infections.
The immune cells of the spinal cord and brain contribute significantly to prolonging survival in a model of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that results in paralysis and eventual death, according to a study published today in Proceedings of the National Academy of Sciences U.S.A.
Two nearly 6-foot tall, remote-controlled robots are now on staff at The Methodist Hospital in Houston, caring for critically ill patients suffering from stroke or other neurological problems.
Two holiday-related stories: One is about heartburn and holiday meals, and the other is about deep vein thrombosis, a potentially-fatal condition that can affect travelers.
This is a study involving obesity and inflammation that could lead to new therapies to prevent diabetes and heart disease.
Data presented indicates effectiveness of new treatment for kidney transplant recipients.
Physicians and researchers in the Methodist Neurological Institute (NI) are studying the use of a novel combination of radiation and suicide gene therapy to treat typically stubborn malignant brain tumors.
Health feature story ideas: 1) Botox for stroke patients; 2) Erectile dysfunction and heart disease; 3) Minimally-invasive procedure for women with heavy menstrual cycles; 4) Acid reflux affecting the voice
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new vascular graft engineered to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.
Experts from the Methodist DeBakey Heart Center are available to discuss implications of a Food and Drug Administration panel that met this week to consider whether drug-eluting stents (DES), heralded devices that have been implanted in four million Americans to prop open clogged arteries, might cause deadly blood clots.
Research published today shows that a combination statin therapy lowers bad cholesterol by an unprecedented 70 percent, and has the added benefit of reducing life-threatening inflammation that can lead to heart disease and stroke. This is the biggest drop in bad cholesterol ever seen in a statin clinical trial.
For more than three decades Houston heart surgeon Dr. Rafael Espada has mended the hearts of his fellow Guatemalans for free. His countrymen have made him a national hero "“ now he is hoping they make him their vice president.
For National Stroke Awareness Month, the Eddy Scurlock Stroke Center at the Methodist Neurological Institute has several story ideas to offer, including research on microbubbles and ultrasound used to destroy clots in stroke patients, and a therapeutic stroke treatment that targets insulin resistance in non-diabetic patients.
New research demonstrates a higher rate of major adverse cardiac events, such as heart attack and need for a repeat procedure, in patients who fall outside the parameters of the FDA's original approval for use of drug-eluting stents. Reported in today's Journal of the American Medical Association (JAMA).
Scientist and inventor Stephen Wong, Ph.D, PE, led teams that developed the first inkjet printer production and the online stock trading system at Charles Schwab.
This is the first functional MRI study to determine how vocal sounds are represented within the brain of an awake zebra finch, a well-studied animal model of vocal learning. Because of many similarities between birdsong and human speech, this research could lead to a better understanding of the cause of stuttering and other speech problems.
A $2.2 million grant from the National Institutes of Health (NIH) will help researchers at the Methodist DeBakey Heart Center identify how weight loss and lifestyle changes affect the risk for heart disease in obese and diabetic patients, a rapidly-growing group in America.
The Methodist Hospital System is one of the nation's most wired systems, according to the 2007 Most Wired Survey and Benchmarking Study. Methodist has ranked in eight of the nine years since this survey began.
A multi-million dollar grant from the United States Department of Defense (DoD) will allow six hospital centers, including the Methodist Neurological Institute (NI), to expand a spinal cord injury research network created by the Christopher Reeve Foundation (CRF). The North American Clinical Trials Network (NACTN) was organized by the CRF to bring promising therapies for spinal cord injury from the laboratory to clinical trials in an effective manner with maximum safety to patients undergoing treatment for their spinal cord injury.
Blood samples from more than 220 ALS patients at the Methodist Neurological Institute were used in research that revealed significant changes in or around 10 specific genes in sporadic ALS, the most common form of ALS. The results were published this week in the New England Journal of Medicine.
A new podcast series will place breaking medical information "in context" to help lay people understand how the latest medical announcements relate to them personally amid the overwhelming and often conflicting volumes of medical information at their fingertips.
September is National Gynecologic Cancer Awareness Month. A breast-ovarian cancer gene test is a blood test that shows whether a woman has breast cancer or ovarian cancer gene mutations, known as BRCA 1 or 2, which increases a woman's chance of having breast, ovarian or other cancers.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
Dr. Gerald Lawrie, a cardiothoracic surgeon with the Methodist DeBakey Heart Center, is the first to use a surgical robot to successfully repair a mitral valve using an advanced technique of repair called the "American Correction."
A new, global trial will provide a head-to-head competition between two popular statin therapies to see which does a better job at lowering the levels of bad cholesterol (LDL-C) in patients' blood.
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new, less-invasive stent graft designed to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.
A new vibrating catheter breaks through clogged arteries like a jackhammer, obliterating total blockages in patients with dangerous chronic total occlusions (CTOs). CTOs develop over time as plaque build-up thickens on the arterial walls, ultimately closing off the artery and preventing oxygenated blood from reaching the patient's leg or foot. This condition left untreated leads to limb amputation.
Researchers have discovered the genetic cause of a medical condition thought to be suffered by Job, a prominent biblical figure who was afflicted with painful sores from the soles of his feet to the top of his head.
A new trial will seek to protect patients from stroke by reversing blood flow in the brain during carotid stenting.
When traveling long distances this holiday season, take heed of the dangers of deep vein thrombosis (DVT), a condition that can result in stroke, organ damage or even death.
Former U.S. Rep. Charlie Wilson was discharged Thursday from The Methodist Hospital in Houston after undergoing a lifesaving heart transplant 10 days ago. As a powerful member of the Defense Appropriations Committee, Wilson helped funnel billions of dollars in U.S. aid to Afghan fighters during the Soviet-Afghan war, which ultimately led to the fall of the Soviet Union. His exploits were chronicled in the best-selling book Charlie Wilson's War, and in a movie this Christmas starring Tom Hanks and Julia Roberts.
Ever wonder why you are fatigued during the day when you thought you slept throughout the night? Why your spouse snores so much? Whether your sleep problems might be related to other health issues? Dr. Aparajitha Verma, neurologist with the Sleep Disorders Center at the Methodist Neurological Institute in Houston, Texas, is here to answer those questions and help you get a good night's rest.
Dr. Michael E. DeBakey was awarded the Congressional Gold Medal Tuesday, the highest civilian award bestowed by the U.S. Congress, for his lifetime of medical achievement and public service.
Epilepsy is one of the world's most common disabling neurological conditions, and it is also one of the most misunderstood. Many people with this neurological disorder often feel stigmatized because of the recurring seizures that can accompany this disease. Dr. Amit Verma, director of neurophysiology at the Methodist Neurological Institute, answers questions about epilepsy, treatment options and educating the public.
Q&A about flu season with Dr. Eric Westerman, an infectious disease expert with The Methodist Hospital in Houston.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented today at the American Heart Association's Scientific Sessions.
Cardiac resynchronization therapy (CRT) showed a lack of benefit for a segment of patients with heart failure. Results presented in a late breaking trial at the American Heart Association Scientific Sessions today show that heart failure patients with normal QRS duration, a surrogate measure of electrical conduction, may not experience any improvement in exercise tolerance after having pacemakers implanted. Results also appear today in the online version of the New England Journal of Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right